OMX Nordic 40
|
2 192,36
|
-18,02
|
-0,82%
|
Analysen zu OMX Nordic 40-Werten
| 16.04.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 16.04.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 15.04.25 | Ericsson Sell | UBS AG | |
| 15.04.25 | ABB Sector Perform | RBC Capital Markets | |
| 15.04.25 | Volvo AB Outperform | RBC Capital Markets | |
| 10.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 10.04.25 | ABB Sell | Deutsche Bank AG | |
| 10.04.25 | AstraZeneca Buy | UBS AG | |
| 09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 08.04.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 08.04.25 | Nokia Buy | Deutsche Bank AG | |
| 08.04.25 | Nokia Market-Perform | Bernstein Research | |
| 08.04.25 | Ericsson Underperform | Bernstein Research | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | ABB Sector Perform | RBC Capital Markets | |
| 04.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Volvo AB Underperform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 01.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | Volvo AB Underperform | Bernstein Research | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Ericsson | 3 |
| Novo Nordisk | 1 |
| ABB | 1 |
| Volvo AB | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.